Oklahoma TSET Phase 1 Program

The Oklahoma TSET Phase I Program at the Stephenson Cancer Center provides an opportunity for cancer patients to participate in “first-in-human” clinical trials to access new and promising investigational agents.

The Oklahoma TSET Phase I Program is ranked among the top 10 Phase I programs in the nation for number of patients participating. It is the only Phase I Program in Oklahoma and surrounding region. To date, the Oklahoma TSET Phase I Program has conducted more than 225 early-phase clinical trials, with more than 1,250 patients participating.

Launched in partnership with Sarah Cannon Research Institute in Nashville, TN, the nation’s largest oncology Phase I center, the Oklahoma TSET Phase I Program is advancing the Stephenson Cancer Center’s mission of improving patient outcomes and raising the standard of cancer care of all Oklahomans.

The Stephenson’s Phase I Program is named in recognition of funding support provided by the Oklahoma Tobacco Settlement Endowment Trust (TSET).